The influence of innate and pre-existing immunity on adenovirus therapy. (25/2207)

Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes. (26/2207)

B-cells get the T-cells but antibodies get the worms. (27/2207)

Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization. (28/2207)

Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. (29/2207)

Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. (30/2207)

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. (31/2207)

Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice. (32/2207)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10